The central role of hyperandrogenism in driving metabolic dysfunction in polycystic ovary syndrome: from pathophysiological mechanisms to targeted therapies. [PDF]
J Ovarian ResXu J, He B.
europepmc +1 more source
Local Radiotherapy and Androgen Deprivation Therapy (ADT) Monotherapy for Low-Volume Metastatic Hormone-Sensitive Prostate Cancer: Real-World Outcomes in the Era of PSMA PET-CT Staging [PDF]
Yuen Hang Lau, Chung Hang James Chow
openalex +1 more source
The Journal of Pathology, EarlyView.Abstract Fibroblast growth factor receptor 1 (FGFR1) amplification, a significant cancer alteration with both prognostic and therapeutic relevance, lacks a standardized definition. The relationship between FGFR1 copy number (CN) variations and tumour microenvironment (TME) characteristics also remains poorly understood.
Yike Gao +6 more
wiley +1 more source
Approach to the patient: investigation of postmenopausal androgen excess.
J Clin Endocrinol MetabMadden-Doyle L +3 more
europepmc +1 more source
Correction: Complete androgen insensitivity syndrome with cryptorchid sertoli cell tumor: a case report and literature review [PDF]
Yuqing Wang +5 more
openalex +1 more source
Prenatal Diagnosis, EarlyView.ABSTRACT Objective To characterize the overall diagnostic yield of sequential chromosomal microarray (CMA) and exome sequencing (ES) across the phenotypic spectrum of fetal growth restriction (FGR). Methods A retrospective cohort of 320 consecutive FGR pregnancies presenting at ≥ 20 weeks to a tertiary fetal medicine unit (2020–2025).
Hadas Miremberg +11 more
wiley +1 more source
Pathways to Effective Treatment for Individuals Convicted of Sexual Offences Who Are Taking Medication to Manage Problematic Sexual Arousal. [PDF]
Sex AbuseLievesley R +4 more
europepmc +1 more source
Talazoparib plus enzalutamide improved rPFS for patients with androgen pathway modulation‐sensitive prostate cancer [PDF]
Leah Lawrence
openalex +1 more source